This inventor holds 1 USPTO granted patent. Top assignee: Beckman Research Institute, City of Hope. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Luis Valiente
Introduction
Luis Valiente is a notable inventor based in Burbank, California. He has made significant contributions to the field of biomedical research, particularly in the characterization of human islets and insulin-producing cells. His work is essential for advancing our understanding of diabetes and related conditions.
Latest Patents
Luis Valiente holds a patent for "Stable dithizone solutions and formulations and methods for their use." This innovative patent describes an optimized Dipheylthiocarbazone or Dithizone (DTZ) solution that possesses preferred physical and chemical properties. The formulation is designed to characterize human islets and insulin-producing cells differentiated from embryonic stem cells. The newly formulated iDTZ (where "i" stands for islet) has been tested over a range of temperatures, time intervals, and cell and tissue types, proving to be robust for identifying these critical cells. Additionally, the iDTZ solution, through high transition zinc binding, concentrates in insulin-producing cells and can be utilized to delineate zinc levels in tissue and liquid samples.
Career Highlights
Luis Valiente is affiliated with the Beckman Research Institute, City of Hope, where he continues to contribute to groundbreaking research. His work has implications for diabetes treatment and understanding cellular functions related to insulin production.
Collaborations
Luis has collaborated with several esteemed colleagues, including Bashar Khiatah and Ismail H Al-Abdullah. Their combined expertise enhances the research efforts at the Beckman Research Institute.
Conclusion
Luis Valiente's innovative work in developing stable dithizone solutions is a testament to his dedication to advancing biomedical research. His contributions are vital for the future of diabetes research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
